Küsnacht, United States of America

Onur Boyman

This inventor holds 1 USPTO granted patent. Top assignee: Unversität Zürich. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Onur Boyman. Retrieved from https://idiyas.com/inventor/onur-boyman-1ewcgzm3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Onur Boyman: Innovator in Immunology

Introduction

Onur Boyman is a notable inventor based in Küsnacht, US. He has made significant contributions to the field of immunology, particularly through his innovative research and development of antibodies.

Latest Patents

Onur Boyman holds a patent for a CD25-biased anti-IL-2 antibody. This invention represents a crucial advancement in therapeutic strategies for various immune-related conditions. He has 1 patent to his name, showcasing his commitment to scientific innovation.

Career Highlights

Currently, Onur Boyman is affiliated with Universität Zürich, where he continues to engage in groundbreaking research. His work at this prestigious institution allows him to collaborate with other leading scientists in the field.

Collaborations

Onur has worked alongside talented colleagues such as Ufuk Karakus and Miro Raeber. Their combined expertise fosters a collaborative environment that enhances the quality and impact of their research.

Conclusion

Onur Boyman is a dedicated inventor whose work in immunology is paving the way for new therapeutic approaches. His contributions, particularly in the development of innovative antibodies, highlight the importance of research in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…